Experiments have shown that tau hyperphosphorylation correlates with the degree of tau aggregation and the pathological severity of Alzheimer’s disease because tau, not β-amyloid, determines cognitive status [9,19]. The gene discussed is MAPT; the disease is Alzheimer disease.